500 related articles for article (PubMed ID: 30011792)
1. Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH).
Chaudhry SR; Hafez A; Rezai Jahromi B; Kinfe TM; Lamprecht A; Niemelä M; Muhammad S
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011792
[TBL] [Abstract][Full Text] [Related]
2. Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review.
Muhammad S; Chaudhry SR; Kahlert UD; Lehecka M; Korja M; Niemelä M; Hänggi D
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295146
[TBL] [Abstract][Full Text] [Related]
3. Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation.
Chaudhry SR; Shafique S; Sajjad S; Hänggi D; Muhammad S
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232519
[TBL] [Abstract][Full Text] [Related]
4. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
[No Abstract] [Full Text] [Related]
5. Temporal profile of serum mitochondrial DNA (mtDNA) in patients with aneurysmal subarachnoid hemorrhage (aSAH).
Chaudhry SR; Frede S; Seifert G; Kinfe TM; Niemelä M; Lamprecht A; Muhammad S
Mitochondrion; 2019 Jul; 47():218-226. PubMed ID: 30529453
[TBL] [Abstract][Full Text] [Related]
6. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
Przybycien-Szymanska MM; Ashley WW
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
[TBL] [Abstract][Full Text] [Related]
7. Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis.
Chaudhry SR; Güresir E; Vatter H; Kinfe TM; Dietrich D; Lamprecht A; Muhammad S
Cytokine; 2017 Sep; 97():96-103. PubMed ID: 28609751
[TBL] [Abstract][Full Text] [Related]
8. Impact of High-Mobility Group Box 1 Polymorphism on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
World Neurosurg; 2017 May; 101():325-330. PubMed ID: 28189859
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive outcomes after aneurysmal subarachnoid hemorrhage: Identifying inflammatory biomarkers.
Watson E; Ding D; Khattar NK; Everhart DE; James RF
J Neurol Sci; 2018 Nov; 394():84-93. PubMed ID: 30240942
[TBL] [Abstract][Full Text] [Related]
10. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis.
Lv SY; Wu Q; Liu JP; Shao J; Wen LL; Xue J; Zhang XS; Zhang QR; Zhang X
World Neurosurg; 2018 Mar; 111():e362-e373. PubMed ID: 29277532
[TBL] [Abstract][Full Text] [Related]
11. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).
Weiland J; Beez A; Westermaier T; Kunze E; Sirén AL; Lilla N
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064048
[TBL] [Abstract][Full Text] [Related]
13. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).
Chaudhry SR; Kinfe TM; Lamprecht A; Niemelä M; Dobreva G; Hänggi D; Muhammad S
Cytokine; 2020 Sep; 133():155142. PubMed ID: 32485621
[TBL] [Abstract][Full Text] [Related]
14. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
[TBL] [Abstract][Full Text] [Related]
15. Elevated HMGB1 and sRAGE levels in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients.
Chu XH; Hu HY; Godje ISG; Zhu LJ; Zhu JB; Feng YL; Wang H; Zhang YB; Huang J; Sun XG
J Stroke Cerebrovasc Dis; 2023 May; 32(5):107061. PubMed ID: 36871437
[TBL] [Abstract][Full Text] [Related]
16. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage.
Chaichana KL; Pradilla G; Huang J; Tamargo RJ
World Neurosurg; 2010 Jan; 73(1):22-41. PubMed ID: 20452866
[TBL] [Abstract][Full Text] [Related]
17. Review of aneurysmal subarachnoid hemorrhage--focus on treatment, anesthesia, cerebral vasospasm prophylaxis, and therapy.
Lin BF; Kuo CY; Wu ZF
Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):77-84. PubMed ID: 25016512
[TBL] [Abstract][Full Text] [Related]
18. Compartmentalisation of the inflammatory response following aneurysmal subarachnoid haemorrhage.
Al-Tamimi YZ; Bhargava D; Orsi NM; Teraifi A; Cummings M; Ekbote UV; Quinn AC; Homer-Vanniasinkam S; Ross S
Cytokine; 2019 Nov; 123():154778. PubMed ID: 31323526
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage.
Sun Q; Wang F; Li W; Li W; Hu YC; Li S; Zhu JH; Zhou M; Hang CH
Med Hypotheses; 2013 Oct; 81(4):681-5. PubMed ID: 23932051
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Biomarkers for Predicting Complications following Aneurysmal Subarachnoid Hemorrhage.
Wang WX; Springer JE; Hatton KW
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
